scholarly journals Advancing Basal Insulin Replacement in Type 2 Diabetes Inadequately Controlled With Insulin Glargine Plus Oral Agents: A Comparison of Adding Albiglutide, a Weekly GLP-1 Receptor Agonist, Versus Thrice-Daily Prandial Insulin Lispro

Diabetes Care ◽  
2014 ◽  
Vol 37 (8) ◽  
pp. 2317-2325 ◽  
Author(s):  
Julio Rosenstock ◽  
Vivian A. Fonseca ◽  
Jorge L. Gross ◽  
Robert E. Ratner ◽  
Bo Ahrén ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Insulin Glargine ◽  
Insulin Lispro ◽  
Basal Insulin ◽  
Receptor Agonist ◽  
Prandial Insulin ◽  
Oral Agents ◽  
Insulin Replacement

Basal insulin glargine vs prandial insulin lispro in type 2 diabetes

The Lancet ◽  
2008 ◽  
Vol 372 (9636) ◽  
pp. 371-372 ◽  
Author(s):  
Juliana Helena Oliveira ◽  
Cristof Kazda ◽  
Alexander Simpson ◽  
Jeffrery A Jackson ◽  
Robert J Heine
Keyword(s):  
Type 2 Diabetes ◽  
Insulin Glargine ◽  
Insulin Lispro ◽  
Basal Insulin ◽  
Prandial Insulin

Basal insulin glargine vs prandial insulin lispro in type 2 diabetes

The Lancet ◽  
2008 ◽  
Vol 372 (9636) ◽  
pp. 370-371 ◽  
Author(s):  
Sabine Arnolds ◽  
Klaus Rave
Keyword(s):  
Type 2 Diabetes ◽  
Insulin Glargine ◽  
Insulin Lispro ◽  
Basal Insulin ◽  
Prandial Insulin

Basal insulin glargine vs prandial insulin lispro in type 2 diabetes – Authors' reply

The Lancet ◽  
2008 ◽  
Vol 372 (9636) ◽  
pp. 372 ◽  
Author(s):  
Thomas Linn ◽  
W Landgraf ◽  
Reinhard G Bretzel
Keyword(s):  
Type 2 Diabetes ◽  
Insulin Glargine ◽  
Insulin Lispro ◽  
Basal Insulin ◽  
Prandial Insulin
Sign in / Sign up

Export Citation Format

Share Document